Profility is a healthcare technology startup that specializes in personalized care planning. Utilizing advanced profiling technology and predictive analytics, the company aims to optimize decisions and transitions within the healthcare ecosystem. The uniqueness of their solution lies in their ability to understand and match patients to clusters of near-clones, drawing on existing data to personalize care beyond the average patient.
Founded in 2010 and headquartered in the United States, Profility received its Series B investment on 10th April 2023 from Valitas Ventures. The company's approach revolves around combining big data with proprietary algorithms to discover hidden patterns and groups of similar patients, ultimately seeking to improve the delivery of healthcare.